Skip to content

Development, formulation and evaluating the efficacy of a hyaluronic acid nano gel for management of traumatic facial abrasions: a randomized controlled trial

Development and formulation of a hyaluronic acid nano gel for management of traumatic facial abrasions: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108091
Enrollment
30
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: Hyaluronic acid nano gel: Topical application of hyaluronic acid nano gel will be performed after cleansing the facial abrasion with sterile normal saline. A thin uniform layer of the g

Sponsors

DR PRAGYA KAUSHIK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients reporting to the hospital within 24 hours of injury. - Patients presenting with facial abrasions of minimum size 2 into 2cm square resulting from traumatic injury. - Patients presenting with grade II i.e. grazed (brush) abrasions11 and/or WHO abrasion Code -ICD-10 S00.83XA Abrasion of face, initial encounter -Patients willing to provide written informed consent for participation in the study. -Patients willing to comply with treatment protocol and follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Patients with systemic conditions affecting wound healing (diabetes, immunocompromised states). 2. Pregnant and lactating women. 3. Patients who smoke regularly. 4. Patients allergic to hyaluronic acid or formulation components. 5. Patients not willing to participate.

Design outcomes

Primary

MeasureTime frame
Change in wound healing status assessed using Bates-Jensen Wound Assessment Tool (BWAT) score following topical application of hyaluronic acid nanoemulsion gel in traumatic facial abrasions.Timepoint: Baseline (Day 0), Day 3, Day 7 and Day 14.

Secondary

MeasureTime frame
Reduction in wound size (surface area of facial abrasion).Timepoint: Baseline (Day 0), Day 3, Day 7, and Day 14.

Countries

India

Contacts

Public ContactDr Pragya Kaushik

KAHER KLE VISHWANATH KATTI INSTITUTE OF DENTAL SCIENCES

dr.sneha009@gmail.com9743003073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026